Vaccines

Politics

Bill Gates and US Trade rep talk vaccines

Microsoft co-founder Bill Gates and United States Trade Representative Katherine Tai held a virtual meeting on Tuesday to discuss increasing COVID-19 vaccine production, global health issues and the proposed waiver to certain provisions of the World Trade Organization’s (WTO) agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) related to the pandemic.

Markets

Moderna CEO: COVID-19 vaccine surplus possible in 2022

Moderna Inc. CEO Stephane Bancel said Friday that the company is on track to produce 1 billion doses of its COVID-19 vaccine this year, but warned that with manufacturers producing large quantities, there could be an oversupply in 2022.

Markets

COVID-19 vaccine start-up files for IPO

The biotech startup behind the COVID-fox19 vaccine jointly developed by AstraZeneca PLC and the University of Oxford filed Friday with U.S. regulators for a public share offering. Vaccitech PLC said in a securities filing it plans to use the technology underpinning the vaccine to develop treatments targeting prostate cancer, hepatitis B and human papillomavirus.